Kuklin Vladimir
Department of Anaesthesiology, Kongsberg Hospital, Kongsberg, Norway.
Saudi J Anaesth. 2013 Jul;7(3):310-4. doi: 10.4103/1658-354X.115355.
Experimental studies both in vivo and in vitro show significantly increased survival rate in animals and in cortical neurons respectively exposed to acute hypoxia and pre-treated with opioids compared to non-treated counterparts. Thus, the main aim of the study was to examine survival rates in patients after sudden cardiac arrest (SCA) in the hospital who were or were not treated with opioids before and/or during cardiac pulmonary resuscitation (CPR).
The registry SCA database at the University Hospital of Northern Norway (UNN) for the period of January 2006-December 2009 was used to obtain data for the evaluation. Inclusion criteria were observed SCA at UNN for patients with American Society of Anesthesiologists (ASA) 1-3. Exclusion criteria included ASA four to five patients and unobserved SCA. Study patients were divided into two groups: Those not treated with opioids and those treated with opioids not more then 3 h before and/or during CPR. Survival rate 1, 2, 3 and 28 days post CPR were compared for the two groups.
A total of 117 patients were registered in the SCA database at UNN for the period from January 2006 to December 2009. Sixty seven patients were excluded from the study: 17 patients had an unknown time of SCA dιbut, two patients had only syncope and 48 were ASA four to five patients. A total of 50 ASA one to three patients were included in the study, 33 and 17 patients respectively in the control and opioid-treated groups. The patients who were treated with opioids before or during CPR had a significantly higher 1, 2, 3 and 28 days survival rate as compared to those receiving only conventional CPR. The model was adjusted for duration of CPR (P=0.047) and treatment with adrenaline (P=0.779) in the groups. Adjusted Odds ratio was 0.075 (95% confidence interval (CI): 0.015-0.387). Relative risk of fatal outcome in the opioids group was 0.2944 (95% CI: 0.1549-0.5594).
Significantly higher 1, 2, 3 and 28 days survival rate and reduced duration of CPR were found in the patients additionally treated with opioids compared to ordinary resuscitation. Further prospective, randomized, controlled trials are needed to investigate the effects of early administration of opioids during CPR on survival and brain function in patients with witnessed in-hospital SCA.
体内和体外实验研究均表明,与未接受治疗的动物和皮质神经元相比,分别暴露于急性缺氧并预先使用阿片类药物治疗的动物和皮质神经元的存活率显著提高。因此,本研究的主要目的是检查在医院发生心脏骤停(SCA)的患者中,在心肺复苏(CPR)之前和/或期间接受或未接受阿片类药物治疗后的存活率。
使用挪威北部大学医院(UNN)2006年1月至2009年12月期间的SCA登记数据库来获取评估数据。纳入标准为在UNN观察到的美国麻醉医师协会(ASA)1-3级患者的SCA。排除标准包括ASA 4至5级患者和未观察到的SCA。研究患者分为两组:未接受阿片类药物治疗的患者和在CPR之前和/或期间接受阿片类药物治疗不超过3小时的患者。比较两组CPR后1天、2天、3天和28天的存活率。
2006年1月至2009年12月期间,UNN的SCA数据库中共登记了117例患者。67例患者被排除在研究之外:17例患者SCA发作时间不明,2例患者仅有晕厥,48例为ASA 4至5级患者。共有50例ASA 1至3级患者纳入研究,对照组和阿片类药物治疗组分别为33例和17例。与仅接受传统CPR的患者相比,在CPR之前或期间接受阿片类药物治疗的患者在1天、2天、3天和28天的存活率显著更高。对两组的CPR持续时间(P=0.047)和肾上腺素治疗(P=0.779)进行了模型调整。调整后的优势比为0.075(95%置信区间(CI):0.015-0.387)。阿片类药物组致命结局的相对风险为0.2944(95%CI:0.1549-0.5594)。
与普通复苏相比,额外接受阿片类药物治疗的患者在1天、2天、3天和28天的存活率显著更高,且CPR持续时间缩短。需要进一步进行前瞻性、随机、对照试验,以研究CPR期间早期使用阿片类药物对医院内目击SCA患者的存活率和脑功能的影响。